Linda P. Oosterveld

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Medicine, Cardiology, Pharmacotherapy +17

CSF or Serum Neurofilament Light Added to α‐Synuclein Panel Discriminates Parkinson's From Controls

Linda P. Oosterveld, Inge M.W. Verberk, Nour K. Majbour et al. · Movement Disorders · 2019 · 97 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Prognostic factors for early mortality in Parkinson's disease

Linda P. Oosterveld, John Carson Allen, Giselle Reinoso et al. · Parkinsonism & Related Disorders · 2014 · 61 citations

Medicine, Neurology, Neuroscience +12

Greater motor progression in patients with Parkinson disease who carry <i>LRRK2</i> risk variants

Linda P. Oosterveld, John Carson Allen, Ebonne Ng et al. · Neurology · 2015 · 33 citations

Life Sciences, Genetics, Neurology +17

Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies

Madhurima Chatterjee, Inger van Steenoven, Evelien Huisman et al. · Biomolecules · 2020 · 30 citations · Full text

Life Sciences, Neurology, Neuroscience +17